MSFKX
Price
$19.84
Change
+$0.04 (+0.20%)
Updated
Jul 3 closing price
Net Assets
7.74B
RLBCX
Price
$36.64
Change
+$0.18 (+0.49%)
Updated
Jul 3 closing price
Net Assets
252.39B
Interact to see
Advertisement

MSFKX vs RLBCX

Header iconMSFKX vs RLBCX Comparison
Open Charts MSFKX vs RLBCXBanner chart's image
MFS Total Return R6
Price$19.84
Change+$0.04 (+0.20%)
VolumeN/A
Net Assets7.74B
American Funds American Balanced R3
Price$36.64
Change+$0.18 (+0.49%)
VolumeN/A
Net Assets252.39B
MSFKX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MSFKX vs. RLBCX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSFKX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. MSFKX (7.74B). MSFKX pays higher dividends than RLBCX: MSFKX (2.62) vs RLBCX (1.57). MSFKX was incepted earlier than RLBCX: MSFKX (13 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than MSFKX (0.40). MSFKX is a more actively managed with annual turnover of: 53.00 vs. RLBCX (44.00). MSFKX has a lower initial minimum investment than RLBCX: MSFKX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 7.52 vs. MSFKX (4.05). RLBCX return over 5 years is better than : 39.59 vs. MSFKX (16.86).
MSFKXRLBCXMSFKX / RLBCX
Total Expense Ratio0.400.8945%
Annual Report Gross Expense Ratio0.400.8945%
Fund Existence13 years23 years-
Gain YTD6.4337.91781%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.74B252B3%
Annual Yield % from dividends2.621.57167%
Returns for 1 year4.057.5254%
Returns for 3 years14.6234.0143%
Returns for 5 years16.8639.5943%
Returns for 10 years38.0762.1461%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDEV15.750.65
+4.30%
GDEV Inc
FN294.665.83
+2.02%
Fabrinet
CGON26.900.22
+0.82%
CG Oncology
PTIX3.46-0.02
-0.57%
Protagenic Therapeutics Inc
NINE0.84-0.02
-2.73%
Nine Energy Service